Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
For the full year, net loss was INR 0.164 million compared to INR 0.007 million a year ago. Basic earnings per share from continuing operations was INR 0.027 compared to basic loss per share from continuing operations of INR 0.001 a year ago. Diluted earnings per share from continuing operations was INR 0.027 compared to diluted loss per share from continuing operations of INR 0.001 a year ago.